Literature DB >> 20194836

Improving local control in rectal cancer: radiation sensitizers or radiation dose?

Joel E Tepper, Andrew Z Wang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20194836     DOI： 10.1200/JCO.2009.26.9787

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Preoperative intensified radiochemotherapy for rectal cancer: experience of a single institution.

Authors:  Francesco Dionisi; Daniela Musio; Nicola Raffetto; Giovanni Codacci-Pisanelli; Eva Iannacone; Rossella Caiazzo; Enzo Banelli
Journal:  Int J Colorectal Dis       Date:  2010-11-25       Impact factor: 2.571

2.  CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α.

Authors:  Xi Tian; Minh Nguyen; Henry P Foote; Joseph M Caster; Kyle C Roche; Christian G Peters; Pauline Wu; Lata Jayaraman; Edward G Garmey; Joel E Tepper; Scott Eliasof; Andrew Z Wang
Journal:  Cancer Res       Date:  2016-10-26       Impact factor: 12.701

3.  Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer.

Authors:  Stuart J Wong; Kathryn Winter; Neal J Meropol; Pramila Rani Anne; Lisa Kachnic; Asif Rashid; James C Watson; Edith Mitchell; Jondavid Pollock; Robert Jeffrey Lee; Michael Haddock; Beth A Erickson; Christopher G Willett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-07-19       Impact factor: 7.038

4.  Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy.

Authors:  Joseph Della Rocca; Michael E Werner; Stephanie A Kramer; Rachel C Huxford-Phillips; Rohit Sukumar; Natalie D Cummings; Juan L Vivero-Escoto; Andrew Z Wang; Wenbin Lin
Journal:  Nanomedicine       Date:  2014-07-17       Impact factor: 5.307

5.  Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART).

Authors:  Umberto Ricardi; Patrizia Racca; Pierfrancesco Franco; Fernando Munoz; Laura Fanchini; Nadia Rondi; Vincenzo Dongiovanni; Pietro Gabriele; Paola Cassoni; Libero Ciuffreda; Mario Morino; Andrea Riccardo Filippi; Massimo Aglietta; Oscar Bertetto
Journal:  Med Oncol       Date:  2013-04-19       Impact factor: 3.064

6.  DNA Repair Deficient Chinese Hamster Ovary Cells Exhibiting Differential Sensitivity to Charged Particle Radiation under Aerobic and Hypoxic Conditions.

Authors:  Ian M Cartwright; Cathy Su; Jeremy S Haskins; Victoria A Salinas; Shigeaki Sunada; Hao Yu; Mitsuru Uesaka; Hirokazu Hirakawa; David J Chen; Akira Fujimori; Takamitsu A Kato
Journal:  Int J Mol Sci       Date:  2018-07-30       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.